It is interesting to me how their stated goals and planned future trajectory sounds like what happend to 'deCODE genetics' an Icelandic genetics company founded

It is interesting to me how their stated goals and planned future trajectory sounds like what happend to 'deCODE genetics' an Icelandic genetics company founded back in 1996 with a focus of "developing novel methods to identity, treat and prevent diseases"[0]. They really were on the forefront at that time, and have been an research powerhouse ever since[1] , but struggled for some time to find a sustainable revenue stream for their discoveries. Shortly after the turn of the millenium they came out with DNA diagnostic kits, that were able to diagnose various things known or thought to increase likelihood of various illnesses and conditions. And this product even came onto the market before 23andme. But since 2012 (I think) they have been an independent research subsidiary of the US pharmaceutical company Amgen, where Amgen then can capitalize on the research output to make the drugs in question (and probably much more that we are not privy to). [0]: https://en.wikipedia.org/wiki/DeCODE_genetics https://en.wikipedia.org/wiki/DeCODE_genetics [1]: https://www.decode.com/publications/ https://www.decode.com/publications/ edit: wording and spelling